Global X Management Company’s Elevance Health ELV Stock Holding History

Global X Management Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.42M	Sell	5,957 -846	-12%	-$196K	0.03%	371
2018 Q1	$1.5M	Sell	6,803 -378	-5%	-$88.8K	0.03%	326
2017 Q4	$1.62M	Buy	7,181 +263	+4%	+$56K	0.04%	274
2017 Q3	$1.31M	Buy	6,918 +833	+14%	+$159K	0.04%	302
2017 Q2	$1.15M	Buy	6,085 +1,619	+36%	+$291K	0.04%	318
2017 Q1	$739K	Buy	4,466 +1,168	+35%	+$186K	0.03%	381
2016 Q4	$474K	Buy	3,298 +701	+27%	+$93.9K	0.02%	398
2016 Q3	$325K	Buy	2,597 +1,677	+182%	+$217K	0.01%	441
2016 Q2	$121K	Buy	920 +309	+51%	+$42.3K	0.01%	479
2016 Q1	$85K	Buy	611 +544	+812%	+$72.7K	0.01%	431
2015 Q4	$9K	Hold	67	–	–	﹤0.01%	575
2015 Q3	$9K	Sell	67 -2	-3%	-$301	﹤0.01%	640
2015 Q2	$11K	Buy	+69	New	+$11K	﹤0.01%	592

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Global X Management Company's ELV Position: Q2 2018 in Review

Global X Management Company reduced its Elevance Health (ELV) stake by 12% in Q2 2018, selling an estimated $196K and leaving 5,957 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #371.

Global X Management Company first reported a position in ELV in Q2 2015 and has held it in 13 quarters since. The position peaked at $1.62M in Q4 2017. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Global X Management Company held 5,957 shares of Elevance Health worth $1.42M as of Q2 2018.
Global X Management Company sold 846 Elevance Health shares in Q2 2018, an estimated $196K.
Elevance Health made up 0.03% of Global X Management Company's portfolio in Q2 2018, its #371 holding.
Global X Management Company first reported a position in Elevance Health in Q2 2015 and has held it in 13 quarters since.
Global X Management Company's Elevance Health position peaked at $1.62M in Q4 2017.
934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.